📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: XO1

1.1 - Company Overview

XO1 Logo

XO1

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of virtual biotechnology development focused on ichorcumab, operating without offices or laboratories by engaging high-quality contract research and development specialists in Europe and the US, managed by a small team of experienced drug developers.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to XO1

Quantum Genomics Logo

Quantum Genomics

HQ: France Website
  • Description: Provider of effective, well-tolerated therapeutic treatments for cardiovascular diseases, focused on controlling high blood pressure and preventing related risks such as heart failure, addressing unmet medical needs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Quantum Genomics company profile →
GENinCode Logo

GENinCode

HQ: United Kingdom Website
  • Description: Provider of genetic testing solutions for cardiovascular disease risk assessment and prediction, combining genetic and clinical data to guide patient evaluation. Offerings include CARDIO inCode-Score for coronary heart disease, LIPID inCode for hyperlipidemia and familial hypercholesterolemia, SUDD inCode for sudden cardiac death, THROMBO inCode for venous thromboembolism, ROCA for ovarian cancer, and SITAB web portal.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GENinCode company profile →
WhiteSwell Logo

WhiteSwell

HQ: Ireland Website
  • Description: Provider of science-driven solutions to improve treatment of acute decompensated heart failure, addressing a leading cause of hospitalization and emergency room visits by investigating the therapeutic potential of the lymphatic system.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full WhiteSwell company profile →
EBR Systems Logo

EBR Systems

HQ: United States Website
  • Description: Provider of wireless cardiac pacing solutions, including the WiSE CRT System for cardiac resynchronization therapy that delivers stimulation directly to the inside of the left ventricle and is designed to overcome limitations of existing CRT systems, leveraging proprietary WiSE Technology for wireless tissue stimulation that eliminates the need for a left-ventricle lead.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EBR Systems company profile →
Arterial Remodeling Technologies Logo

Arterial Remodeling Technologies

HQ: France Website
  • Description: Provider of bioresorbable peripheral and coronary polymer stents that promote the natural remodeling of injured arteries after angioplasty.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arterial Remodeling Technologies company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for XO1

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to XO1

2.2 - Growth funds investing in similar companies to XO1

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for XO1

4.2 - Public trading comparable groups for XO1

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to XO1

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About XO1

What does XO1 do?

XO1 is a provider of virtual biotechnology development focused on ichorcumab, operating without offices or laboratories by engaging high-quality contract research and development specialists in Europe and the US, managed by a small team of experienced drug developers.

Who are XO1's competitors?

XO1's competitors and similar companies include Quantum Genomics, GENinCode, WhiteSwell, EBR Systems, and Arterial Remodeling Technologies.

Where is XO1 headquartered?

XO1 is headquartered in United Kingdom.

How many employees does XO1 have?

XO1 has 1,000 employees 🔒.

When was XO1 founded?

XO1 was founded in 2010 🔒.

What sector and industry vertical is XO1 in?

XO1 is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for XO1

Who are the top strategic acquirers in XO1's sector and industry

Top strategic M&A buyers and acquirers in XO1's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for XO1?

Top strategic M&A buyers groups and sectors for XO1 include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in XO1's sector and industry vertical

Which are the top PE firms investing in XO1's sector and industry vertical?

Top PE firms investing in XO1's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in XO1's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in XO1's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in XO1's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to XO1 include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in XO1's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for XO1?

The key public trading comparables and valuation benchmarks for XO1 include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for XO1 for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for XO1 with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in XO1's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for XO1 with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in XO1's' sector and industry vertical?

Access recent funding rounds and capital raises in XO1's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for XO1